See also this year's filing and all EDGAR filings for this company.
PDF Report 0001452011_2013_Tanke_Biosciences_Corp.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001452011, Tanke Biosciences Corp
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 1,238,025 |
| 1 | AssetsCurrent | 22,367,919 |
| 2 | PropertyPlantAndEquipment | 4,813,232 |
| 3 | remainder_Assets | 429,984 |
| 4 | LiabilitiesLongTerm | 792,567 |
| 5 | LiabilitiesCurrent | 12,095,685 |
| 6 | remainder_Liabilities | 37,948 |
| 7 | GeneralAndAdministrativeExpense | 2,571,671 |
| 8 | SellingAndMarketingExpense | 2,679,714 |
| 9 | remainder_Expenses | 23,835,004 |
| 10 | remainder_Revenues | 28,561,829 |
| 11 | remainder_NetIncome | 295,556 |
| 12 | remainder_ComprehensiveNetIncome | 126,220 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 28,849,160 |
| 1 | Liabilities | 12,926,200 |
| 2 | Expenses | 29,086,389 |
| 3 | Revenues | 28,561,829 |
| 4 | StockholdersEquity | 15,922,960 |
| 5 | NetIncome | -229,004 |
| 6 | ComprehensiveNetIncome | -102,784 |
| 7 | BaseVar | 49,922,677 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.376 |
| 9 | EconomicCapitalRatio | 1.65 |
Edgar->Model Mapping
Feature Distribution
Change over Time
